Wednesday, September 23, 2015

Price Gouging Drug CEO Claims He’s The Good Guy





The CEO of Turing Pharmaceuticals is defending his decision to raise the price of the drug Daraprim 5500%, from $13.50 to $750. He claims his company was not making a profit from the drug and that what he did was actually “altruistic.” Cenk Uygur and Ana Kasparian (The Point) hosts of The Young Turks discuss.


Do you think altruism was a factor in this CEO raining the price of the drug? Should the government implment restriction on how expensive medicines can be? Let us know in the comments below.

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.